- Home
- FMX vs WAT Comparison
FMX vs WAT Comparison
Compare FMX & WAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FMX | WAT |
|---|---|---|
| Founded | 1890 | 1958 |
| Country | Mexico | United States |
| Employees | N/A | N/A |
| Industry | Beverages (Production/Distribution) | Biotechnology: Laboratory Analytical Instruments |
| Sector | Consumer Staples | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 38.1B | 33.5B |
| IPO Year | 1998 | 1996 |
Fundamental Metrics
Financial Performance| Metric | FMX | WAT |
|---|---|---|
| Price | $124.04 | $394.33 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 6 | 17 |
| Target Price | $113.17 | ★ $379.19 |
| AVG Volume (30 Days) | 505.3K | ★ 850.2K |
| Earning Date | 04-30-2026 | 05-05-2026 |
| Dividend Yield | ★ 6.30% | N/A |
| EPS Growth | N/A | ★ 0.47 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $10.20 | $104.66 |
| Revenue Next Year | $8.32 | $10.40 |
| P/E Ratio | $40.94 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $83.08 | $275.05 |
| 52 Week High | $141.47 | $414.15 |
Technical Indicators
Market Signals| Indicator | FMX | WAT |
|---|---|---|
| Relative Strength Index (RSI) | 43.66 | 62.85 |
| Support Level | $120.13 | $372.18 |
| Resistance Level | $124.56 | $411.41 |
| Average True Range (ATR) | 4.44 | 13.24 |
| MACD | -0.70 | 2.09 |
| Stochastic Oscillator | 12.02 | 91.62 |
Price Performance
Historical ComparisonAbout FMX Fomento Economico Mexicano S.A.B. de C.V.
Mexico-based Femsa is a beverage and retail conglomerate in Central and South America. The holding company owns controlling stakes in bottler Coca-Cola Femsa (47% economic stake, 56% voting rights), in addition to operating 100%-owned retail assets, including convenience stores under the Oxxo banner, drugstores, and gas stations. The firm divested its 15% stake in Heineken and its distribution business in 2023. Coca-Cola Femsa and the Oxxo chain made up 75% of total company revenue and over 90% of profits in 2024.
About WAT Waters Corporation
Waters sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. In early 2026, Waters merged with BD's life science and diagnostics business, which increased its concentration in diagnostics (versus none now) and discovery-related life science tools.